9 Meters Biopharma, Inc., a clinical-stage company focused on rare and unmet needs in gastroenterology, announced their collaboration with the Celiac Disease Foundation to support clinical trial enrollment in 9 Meters’ Phase 3 study, CeDLara, for their drug candidate larazotide in celiac disease.
The Celiac Disease Foundation is pleased to partner with 9 Meters to help enroll patients into this important clinical trial. For a large percentage of the celiac disease community, a gluten-free diet is not an adequate treatment to manage celiac disease. We are hopeful that this study will lead to an adjunct treatment with a gluten-free diet. Read more about the drug candidate here.